Prevalence of HBV genotypes in asymptomatic carrier residents and their clinical characteristics during long-term follow-up: the relevance to changes in the HBeAg/anti-HBe system

被引:15
作者
Ishikawa, K
Koyama, T
Masuda, T
机构
[1] Iwate Prefectural Univ, Dept Nursing, Takizawa, Iwate 0200173, Japan
[2] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate 0208505, Japan
[3] Iwate Prevent Med Soc, Morioka, Iwate 0208505, Japan
关键词
asymptomatic carrier; HBeAg; anti-HBe; HBV-DNA; genotype;
D O I
10.1016/S1386-6346(02)00017-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Randomly selected 50 asymptomatic hepatitis B virus (HBV) carrier residents who had been followed annually were enrolled in this study. The subject group comprised 25 males and 25 females with a mean age at the start of follow-up of 44.1 +/- 10.4 years. The mean follow-up period was 15.5 +/- 2.7 years. Genotyping revealed 27 (54%) of genotype B and 23 (46%) of genotype C. The prevalence of genotype B was clearly higher in asymptomatic HBV carrier redidents, which was contrary to the previous reports on chronic liver disease. At the start of follow-up, the ratio of carriers positive for anti-HBe was significantly higher in genotype B than genotype C (P < 0.001). Furthermore, the ratio of carriers with reduced HBV-DNA levels was significantly higher in genotype B than genotype C (P < 0.01), suggesting that most genotype B carriers had already undergone seroconversion from HBeAg to anti-HBe and were clinically stable at the start of follow-up. The subsequent follow-up observations demonstrated that levels of HBV-DNA and ALT were lower in genotype B than genotype C. Seroconversion from HBeAg to anti-HBe was less likely to occur in genotype C carriers, especially on 40-year-old generation, and these subjects were more likely to develop chronic liver disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 12 条
[1]   WILD-TYPE AND E-ANTIGEN-MINUS HEPATITIS-B VIRUSES AND COURSE OF CHRONIC HEPATITIS [J].
BRUNETTO, MR ;
GIARIN, MM ;
OLIVERI, F ;
CHIABERGE, E ;
BALDI, M ;
ALFARANO, A ;
SERRA, A ;
SARACCO, G ;
VERME, G ;
WILL, H ;
BONINO, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4186-4190
[2]   NATURAL-HISTORY AND PROGNOSTIC FACTORS FOR CHRONIC HEPATITIS TYPE-B [J].
FATTOVICH, G ;
BROLLO, L ;
GIUSTINA, G ;
NOVENTA, F ;
PONTISSO, P ;
ALBERTI, A ;
REALDI, G ;
RUOL, A .
GUT, 1991, 32 (03) :294-298
[3]   Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay [J].
Kamisango, K ;
Kamogawa, C ;
Sumi, M ;
Goto, S ;
Hirao, A ;
Gonzales, F ;
Yasuda, K ;
Iino, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :310-314
[4]   Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B [J].
Kao, JH ;
Chen, PJ ;
Lai, MY ;
Chen, DS .
GASTROENTEROLOGY, 2000, 118 (03) :554-559
[5]   Genoepidemiology and its relationship to clinical features in patients infected chronically with hepatitis B virus (HBV) [J].
Kikuchi, K ;
Niitsuma, H ;
Ishii, M ;
Cervantes, JG ;
Hong, SH ;
Ojima, T ;
Suzuki, C ;
Kobayashi, T ;
Ueno, Y ;
Kobayashi, K ;
Shimosegawa, T ;
Toyota, T .
HEPATOLOGY RESEARCH, 2000, 17 (01) :43-55
[6]   Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? [J].
Mayerat, C ;
Mantegani, A ;
Frei, PC .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (04) :299-304
[7]   Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns [J].
Mizokami, M ;
Nakano, T ;
Orito, E ;
Tanaka, Y ;
Sakugawa, H ;
Mukaide, M ;
Robertson, BH .
FEBS LETTERS, 1999, 450 (1-2) :66-71
[8]  
Niitsuma H, 1997, AM J GASTROENTEROL, V92, P119
[9]  
NIITSUMA H, 1999, ACTA HEPATOL JPN, V40, P346
[10]   A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C [J].
Orito, E ;
Mizokami, M ;
Sakugawa, H ;
Michitaka, K ;
Ishikawa, K ;
Ichida, T ;
Okanoue, T ;
Yotsuyanagi, H ;
Iino, S .
HEPATOLOGY, 2001, 33 (01) :218-223